touchREVIEWS in RMD
touchREVIEWS in RMD is a peer-reviewed, free-to-access, bi-annual journal, specializing in the publication of balanced articles written by leading authorities to address the most important and salient developments in the field of rheumatic and musculoskeletal disorders.
The journal is of interest to physicians, healthcare professionals, nurses and researchers, providing practical advice relevant to the clinical setting on diagnosis and treatment in rheumatic and musculoskeletal disorders. The journal endeavours to support these professionals in continuously developing their knowledge, effectiveness and productivity.
Editor-in-Chief: Peter C. Taylor, Professor of Musculoskeletal Sciences at the University of Oxford, Oxford, UK.
Electronic ISSN: 2635-1420Â Â DOI: doi.org/10.17925
Established: January 2021 Frequency: Bi-annual
Abstracting and indexing: touchREVIEWS in RMD is abstracted, indexed and listed in Google Scholar, EBSCO, EMBASE, and ICI Journals Master List.
Accepted article types: Reviews, original research, editorials, commentaries, case reports, and practice pearl articles.
Dear readers, It is a great pleasure to take on the role of Editor-in-Chief of touchREVIEWS in RMD, and I am grateful for the opportunity to introduce myself and to share my vision for the journal. I am a Professor ...
The landscape of rheumatic and musculoskeletal disease research continues to evolve at pace, driven by scientific innovation, interdisciplinary collaboration and an increasing appreciation of the heterogeneity and complexity of the conditions we treat. As we welcome readers to touchREVIEWS in ...
Interstitial lung disease (ILD) is recognized as one of the most frequent and potentially life-threatening pulmonary complications of systemic autoimmune rheumatic diseases (SARDs), a group of rare chronic inflammatory conditions characterized by autoimmune system dysregulation and chronic systemic inflammation. ILDs ...
The importance of multi-disciplinary clinics for the assessment of patients with interstitial lung disease (ILD) is well established, and these are usually led by chest physicians.1Â The role of rheumatologists in such a setting has evolved more recently.2Â The main ...
Virtual reality (VR) is an emergent technology with the potential for genuine impact as a novel, immersive digital therapeutic in healthcare. Within rheumatological conditions, pervasive symptoms including chronic pain and kinesiophobia (fear of movement) are difficult to manage using conventional ...
Why do we need to identify arthritis? In children, joint pain occurs frequently; it is usually associated with activities or accidental falls and is generally short-lived. A small proportion of children have more persistent joint pain, and in this group, ...
From advances in targeted therapies to the integration of AI and steps towards precision medicine, 2024 brought many exciting developments in the field. With 2025 now unfolding, many of these are likely to continue gaining momentum and potentially redefine patient care. In ...
Rheumatoid arthritis (RA) is one of the most challenging autoimmune diseases. Early, targeted and effective therapy is crucial for achieving remission and preventing long-term joint destruction. Over the past two decades, tumour necrosis factor (TNF) inhibitors (TNFi) have been the ...
The use of immune checkpoint inhibitors (ICIs) in treating cancer has greatly improved survival outcomes, particularly in patients with advanced disease for whom successful treatment options have previously been limited. For example, in patients with metastatic melanoma, the median survival ...
Hypermobility spectrum disorders (HSDs) refer to a group of conditions characterized by an increased range of motion in joints beyond the normal limits, often due to connective tissue laxity. More stringent criteria are applied in the diagnosis of hypermobile Ehlers–...
There is much excitement about the deployment of artificial intelligence (AI) in healthcare, and the musculoskeletal field is no exception. In this article, we introduce some of the latest developments relating to osteoarthritis (OA), osteoporosis, rheumatoid arthritis (RA) (as an ...
International experts from the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) have recently partnered to produce the much-anticipated classification criteria for antiphospholipid syndrome (APS), which were published in Arthritis & Rheumatology in August 2023.1 ...
Chronic back pain (CBP), defined as back pain lasting for 3 months or more, is the most common pain condition globally.1 Greater healthcare utilization, productivity limitations and poor quality of life have immediate and long-term impacts on patients and the healthcare ...
This corrects the article: “Gheriani GA, Tuetken R and Lenert P. Lane–Hamilton Syndrome: A Vasculitis Mimic Presenting with Diffuse Alveolar Haemorrhage and Positive ANCA Testing. touchREVIEWS in RMD. 2024;3(1):37–42” The patient consent statement was added incorrectly due to an editorial ...
It is increasingly recognized that autoimmune rheumatic diseases (ARDs) can affect people of any age, starting from early childhood and continuing until later in life. Furthermore, in recent decades, it has become apparent that Sjögren disease (SjD), commonly diagnosed ...
This editorial outlines a clinical approach to patients with periodic inflammation of unknown origin despite initial rational and targeted investigation. The focus of the editorial is on the recognition and diagnosis of systemic autoinflammatory diseases (SAIDs). Although rare, SAIDs are ...
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Keep track of your clinical interests and newsletter subscriptions.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Already registered? Login below.